Apply Social Health Insurance

JAKARTA, KOMPAS.com - The government should immediately start the implementation of social health insurance which covers the entire population of Indonesia. It was necessary to overcome the various problems in the health sector and accelerate the achievement of the Millennium Development Goals targets.

It was raised in the Editor's Roundtable Discussion on "Health Sector Reform" in Indonesia organized by the Center for Strategic and International Studies (CSIS), Monday (9 / 11) in Jakarta.

Law Number 40 Year 2004 on National Social Security System (Forecast) mandated social health insurance is implemented in five years.

Until now, government regulations to implement the Navigation Act had also been prepared. Instead, the Government launched the Health Insurance for Poor Families (Askeskin) which changed its name to Community Health Insurance Program (Jamkesmas) to finance the treatment of the poor.

According to the medical observer who is also former Chairman of the Executive Board of the Indonesian Doctors Association, Kartono Mohammad, Jamkesmas not insurance, but social assistance for the poor. It will not sustain (ongoing) and the state's financial burden. Therefore, insurance must be made covering the entire population of Indonesia as mandated Main Navigation.

Implementation of health insurance is expected to overcome the problem of drug prices set to remember types of insurance and drug administration by doctors audited by insurance.

Equitable distribution of health personnel and facilities is also expected to be achieved because the doctors are not paid directly by the patient, but by insurance. Insurance, supported by local government commitment in accordance with the spirit of regional autonomy, the doctor can adjust the distribution of income as well as ensuring the doctor based on the number and location of population health must be maintained.

Ori Andari Sutadji, former president director of PT Askes, declared, in the health social insurance cross-subsidies occur from participants, while the premiums of poor people covered by the state. So it could happen sustainability of health funding.

100-day program

On the same day the Minister of Health explained Sedyaningsih Endang Rahayu 100-day program in the health sector of DPR Commission IX.

One of the spotlight is Jamkesmas sustainability. A number of members of Commission IX requested that the program was immediately changed. Member of Commission IX of the PDI-P faction, Surya Chandra Surapaty, hoping the government does not continue the program and encourage Jamkesmas National Social Security System is immediately run. "Roadmap 2014 Universal Health Insurance should refer to the Forecast," he said.

Endang explained, five key issues in health development in the 100-day program, namely to increase health funding to Jamkesmas. Improving public health to accelerate the achievement of MDG targets through improving rural public health, provision of drinking water facilities, restrictions on the highest retail price of generic drugs logo. Control of disease (HIV / AIDS, malaria, and tuberculosis) and prevention of health problems due to the disaster, also increase the availability, distribution, and quality of health personnel, particularly in remote areas, left, border and island.

Meanwhile, CSIS suggested roadmap for the health sector are formulated jointly by the various elements of stakeholders, such as policy makers, academics, practitioners, analysts, economists, industry, health insurance, and associations in the health sector.

According Djisman Simanjuntak of CSIS, to provide access to quality health services and affordable, reduce infant mortality, improving maternal health and combating infectious diseases is the MDG's target and improve the Human Development Index ranked Indonesia, needs to be some policy priorities.

Some priorities include a policy shift from curative to preventive orientation and promotion, health funding shift from cash and fee for service to the health social insurance, and direct the policies and strategies towards achieving the national pharmaceutical independence, resilience, and state revenues.